Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis
- 27 June 2015
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 74 (10) , 911-918
Abstract
The purpose of this study was to compare the diagnostic performance of anti-mutated citrullinated vimentin (anti-MCV) and anti-cyclic citrullinated peptide (anti-CCP) antibodies in rheumatoid arthritis (RA).Keywords
This publication has 42 references indexed in Scilit:
- Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid ArthritisInternational Journal of Rheumatology, 2012
- Diagnostic value of anti‐modified citrullinated vimentin in rheumatoid arthritisInternational Journal of Rheumatic Diseases, 2010
- Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritisAnnals of the Rheumatic Diseases, 2010
- Comparative Performance Analysis of 4 Different Anti-Citrullinated Protein Assays in the Diagnosis of Rheumatoid ArthritisThe Journal of Rheumatology, 2009
- Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapyArthritis Research & Therapy, 2008
- Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort studyArthritis Research & Therapy, 2008
- Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisArthritis & Rheumatism, 2007
- Comparison of Anti-mutated Citrullinated Vimentin with Anti-cyclic Citrullinated Peptide and Rheumatoid Factors for the Diagnostic Value of Rheumatoid ArthritisThe Journal of the Korean Rheumatism Association, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986